Achieving optimal glycaemic control in people with T1DM [1,2] and advanced T2DM [5] often requires intensive insulin therapy, which involves either use of insulin pumps or multiple daily insulin injections (MDI) [1,2,5]. The gene discussed is INS; the disease is type 1 diabetes mellitus.